Anti-RNF103 monoclonal antibody

Pre-made anti-RNF103 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RNF103/RNF103 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1500-Ab-1/ GM-Tg-hg-IP1500-Ab-2Anti-Human RNF103 monoclonal antibodyHuman
GM-Tg-rg-IP1500-Ab-1/ GM-Tg-rg-IP1500-Ab-2Anti-Rat RNF103 monoclonal antibodyRat
GM-Tg-mg-IP1500-Ab-1/ GM-Tg-mg-IP1500-Ab-2Anti-Mouse RNF103 monoclonal antibodyMouse
GM-Tg-cynog-IP1500-Ab-1/ GM-Tg-cynog-IP1500-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF103 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1500-Ab-1/ GM-Tg-felg-IP1500-Ab-2Anti-Feline RNF103 monoclonal antibodyFeline
GM-Tg-cang-IP1500-Ab-1/ GM-Tg-cang-IP1500-Ab-2Anti-Canine RNF103 monoclonal antibodyCanine
GM-Tg-bovg-IP1500-Ab-1/ GM-Tg-bovg-IP1500-Ab-2Anti-Bovine RNF103 monoclonal antibodyBovine
GM-Tg-equg-IP1500-Ab-1/ GM-Tg-equg-IP1500-Ab-2Anti-Equine RNF103 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1500-Ab-1/ GM-Tg-hg-IP1500-Ab-2; GM-Tg-rg-IP1500-Ab-1/ GM-Tg-rg-IP1500-Ab-2;
GM-Tg-mg-IP1500-Ab-1/ GM-Tg-mg-IP1500-Ab-2; GM-Tg-cynog-IP1500-Ab-1/ GM-Tg-cynog-IP1500-Ab-2;
GM-Tg-felg-IP1500-Ab-1/ GM-Tg-felg-IP1500-Ab-2; GM-Tg-cang-IP1500-Ab-1/ GM-Tg-cang-IP1500-Ab-2;
GM-Tg-bovg-IP1500-Ab-1/ GM-Tg-bovg-IP1500-Ab-2; GM-Tg-equg-IP1500-Ab-1/ GM-Tg-equg-IP1500-Ab-2
Products NameAnti-RNF103 monoclonal antibody
Formatmab
Target NameRNF103
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RNF103 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1500-Ag-1Recombinant multi-species RN103/ RNF103/ HKF-1 protein


    Target information

    Target IDGM-IP1500
    Target NameRNF103
    Gene ID7844,22644,84508,511639,100052907
    Gene Symbol and SynonymsAdrg34,HKF-1,KF-1,KF1,RNF103,ZFP-103,ZFP103
    Uniprot AccessionO00237,Q9EPZ8
    Uniprot Entry NameRN103_HUMAN,RN103_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000239305
    Target ClassificationN/A

    The target: RNF103, gene name: RNF103, also named as HKF-1, KF-1, KF1, ZFP-103, ZFP103. The protein encoded by this gene contains a RING-H2 finger, a motif known to be involved in protein-protein and protein-DNA interactions. This gene is highly expressed in normal cerebellum, but not in the cerebral cortex. The expression of the rat counterpart in the frontal cortex and hippocampus was shown to be induced by elctroconvulsive treatment (ECT) as well as chronic antidepressant treatment, suggesting that this gene may be a molecular target for ECT and antidepressants. The protein is a ubiquitin ligase that functions in the endoplasmic reticulum-associated degradation pathway. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream CHMP3 (charged multivesicular body protein 3) gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.